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Purpose: It is crucial for the treatment of severe ocular surface diseases such as Stevens-Johnson syndrome (SJS) and
ocular cicatricial pemphigoid (OCP) to find strategies that avoid the risks of allograft rejection and immunosuppression.
Here, we report a new strategy for reconstructing the damaged corneal surface in a goat model of total limbal stem cell
deficiency (LSCD) by autologous transplantation of epidermal adult stem cells (EpiASC).
Methods: EpiASC derived from adult goat ear skin by explant culture were purified by selecting single cell-derived
clones. These EpiASC were cultivated on denuded human amniotic membrane (HAM) and transplanted onto goat eyes
with total LSCD. The characteristics of both EpiASC and reconstructed corneal epithelium were identified by histology
and immunohistochemistry. The clinical characteristic of reconstructed corneal surface was observed by digital camera.
Results: Ten LSCD goats (10 eyes) were treated with EpiASC transplantation, leading to the restoration of corneal
transparency and improvement of postoperative visual acuity to varying degrees in 80.00% (8/10) of the experimental
eyes. The corneal epithelium of control groups either with HAM transplantation only or without any transplantation
showed irregular surfaces, diffuse vascularization, and pannus on the entire cornea. The reconstructed corneal epithelium
(RCE) expressed CK3, CK12, and PAX-6 and had the function of secreting glycocalyx-like material (AB-PAS positive).
During the follow-up period, all corneal surfaces remained transparent and there were no serious complications. We also
observed that the REC expressed CK1/10 weakly at six months after operation but not at 12 months after operation,
suggesting that the REC was derived from grafted EpiASC.
Conclusions: Our results showed that EpiASC repaired the damaged cornea of goats with total LSCD and demonstrated
that EpiASC can be induced to differentiate into corneal epithelial cell types in vivo, which at least in part correlated with
down-regulation of CK1/10 and upregulation of PAX-6.
The integrity of the normal ocular surface depends on its
epithelial stem cells located at the limbus, termed limbal stem
cells  (LSCs).  LSCs  serve  as  the  ultimate  source  for
maintenance  and  regeneration  of  the  corneal  epithelium
[1-3]. Damage to the limbus can result in limbal stem cell
(LSC)  deficiency,  characterized  by  conjunctivalization,
vascularization,  and  chronic  inflammation  (reviewed  in
Espana et al.) [4]. Transplantation of cultivated LSCs for
reconstructing the ocular surface of total LSC deficiency is
one recently developed treatment [5-8]. Damaged corneas
have  been  successfully  reconstructed  by  transplanting
autologous limbal epithelial cells [7,8] but not in severe ocular
surface diseases such as Stevens-Johnson syndrome (SJS) and
ocular cicatricial pemphigoid (OCP). In the case of severe
ocular diseases, the bilateral damage to LSCs and the immune
response to heterologous corneal epithelial transplantation are
the most challenging clinical entities. Therefore, our goal was
Correspondence to: Professor Zhongying Dou, Northwest A & F
University,  Shaanxi  Branch  of  National  Stem  Cell  Engineering
Center, Yangling, 712100, China; Phone: 86-29-87080068; FAX:
86-29-87080068; email: douzhongying@china.com
to examine whether epidermal stem cells possess the capacity
to activate corneal genetic programs in response to corneal
stromal stimuli.
It  is  widely  accepted  that  epidermis  and  corneal
epithelium are derived from ectoderm during embryogenesis.
A  comparison  of  the  corneal  epithelium  and  follicular
epidermis illustrates that keratinocyte stem cells of these two
systems share several important attributes (reviewed in Taylor
et al.) [9]. These two cell types express the same markers such
as protein 63 (P63), β1-integrin, and cytokeratin 19 (CK19)
[10-12]. Ferraris et al. and Pearton et al. [13,14] have shown
that the transient amplifying (TA) cells of the central corneal
epithelium  can  be  converted  into  the  epidermis  and  its
appendages. This reprogramming occurs by means of a multi-
step process that involves the de-differentiation of TA cells
into primitive stem cells followed by re-differentiation into
hair follicles and associated multipotent stem cells [14]. Liang
and  Bickenbach  [15,16]  have  demonstrated  that  somatic
epidermal  adult  stem  cells  (EpiASC)  have  the  ability  to
produce cells of different lineages during development and
suggested that EpiASC may have pluripotentiality similar to
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1064embryonic  stem  cells  (ESC).  These  authors  co-cultured
EpiASC  with  embryonic  stem  cells  or  transfected
keratinocytes with Octamer-4 (Oct4) and found that EpiASC
could alter their cell lineage protein expression to that of a
more primitive cell type [17,18]. Thus, the microenvironment
of the organ’s structure induces cells of various origins and
degrees of stemness to undergo a 'functional adaptation' to fit
into the overall role of the host organ [19]. This implies that
EpiASC  might  convert  into  corneal  cell  types  when
recombined by the corneal stroma in vivo and also suggests
that transplantation of EpiASC may be a good way of solving
the clinical problems encountered in severe ocular diseases.
It is well known that EpiASC in vivo are harbored in
niches, which keep them in a state of quiescence and stemness
[20-22]. EpiASC are surrounded by a group of TA cells, which
become active and proliferate in culture [23,24]. TA cells may
play an important role in keeping EpiASC quiescent and in
protecting  them  from  damage  [9,25,26].  However,
purification of EpiASC is still problematic because of the
absence of a reliable, specific marker. Many researchers have
reported the isolation of EpiASC from the skin by digesting
the  explants  with  enzymes  such  as  trypsin  and  dispase
(reviewed in Kaur et al.) [27]. To address this purification
problem, we used a recently developed strategy to isolate and
purify EpiASC [28]. To identify whether EpiASC can convert
into corneal cell types when recombined by the corneal stroma
in vivo, we developed a method of culturing EpiASC on
denuded  human  amniotic  membrane  (HAM)  and  then
transplanted the resulting autologous EpiASC-HAM sheet
(EHS) onto the ocular surface of a goat model of limbal stem
cell deficiency (LSCD). The clinical outcome was assessed
after 30 months of follow up [29].
METHODS
Isolation and identification of epidermal stem cells from the
goat ear skin: The isolation and identification of epidermal
stem  cells  were  performed  as  previously  described  [28].
Briefly, pieces of skin approximately 0.5 cm × 0.6 cm were
cut from the ear of Guanzhong dairy goats (three to four years
old). The tissues were rinsed three times with Medium 199
(Invitrogen-Gibco BRL, Grand Island, NY), which contained
50 μg/ml gentamicin and 1.25 μg/ml amphotericin B. After
the careful removal of cartilage and conjunctive tissue, the
remaining tissue was moved to a culture dish and cut into
pieces approximately 1 mm × 2 mm × 3 mm using a scalpel.
We then placed three to four pieces of the explant into each
well of a six-well TC-Plate (Hyclone, Logan, UT) and added
Medium  199  (Invitrogen-Gibco  BRL,  Grand  Island,  NY)
supplemented  with  15%  neonatal  bovine  serum  (Baian
Biotechnology Corporation, Zhengzhou City, China), 5 μg/ml
insulin (Sigma-Aldrich Corporation, St. Louis, MO), 0.5 μg/
ml  hydrocortisone,  40  μg/ml  gentamicin,  and  0.25  μg/ml
amphotericin B. The explants were cultured at 37 °C in a 5%
CO2 /95% air incubator. The medium was changed every two
to  three  days  while  the  extent  of  each  outgrowth  was
monitored with a phase contrast microscope. We selected the
holoclones under dissecting microscope and treated them with
0.2% trypsin and 0.02% EDTA for approximately 10 min to
disperse  each  clone  to  single  cells.  The  trypsin  was  then
inactivated by adding a medium containing 20% serum, and
cells were gently centrifuged and resuspended in a serum free
medium. The selected cells were seeded into culture dishes
coated with gelatin type B (Sigma) in a medium containing
80% Ham F12 (Invitrogen-Gibco BRL, Grand Island, NY),
20% GSFCM (goat skin fibroblast-conditioned medium), 1 -
2% BSA (Sigma-Aldrich, St. Louis, MO), 20 ng/ml EGF
(Sigma), 20 ng/ml IGF-1 (Sigma), 5 μg/ml insulin, 0.5 μg/ml
hydrocortisone, and 50 μg/ml penicillin and streptomycin.
Primary putative epidermal stem cells were left to grow
until they reached about 70% confluence in the culture plate.
Adherent cells were then harvested with 0.2% trypsin and
0.02% EDTA to dislodge the cells followed by rapid trypsin
neutralization  to  prevent  cell  damage.  Isolated  single  cell
suspensions were subcultured on culture dishes coated with
gelatin at final plating density of 0.5–2 × 105 viable cells per
well. At each passage, cells from one well out of a set of
triplicate  cultures  were  detached,  pooled,  centrifuged,
resuspended in fresh growth medium, seeded into three new
wells, and expanded until they reached the same level of
confluence. The growth medium was changed completely
every other day. The cultures were monitored under a Leica
Microsystems Wetzier microscope, LEICA MPS 60 (Leitz,
Wetzlar, Germany).
To  confirm  the  EpiASC  derived  from  interfollicular
epidermis, we dissected epidermis from dermis as previously
described [30] with the following modifications. Skin samples
were treated with 0.5% dispase II (Boehringer, Ingelheim,
Germany) for 14–16 h at 4 °C to separate the interfollicular
epidermis  as  a  sheet  from  the  underlying  dermal  tissue,
leaving the hair follicular from the infundibulum to the dermal
papillae within the dermis. The dermal surface was brushed
gently with curved forceps to release any loosely attached
basal keratinocytes, and then both interfollicular epidermis
and dermis were cultured in the same medium. The cultures
were  monitored  under  a  Leica  Microsystems  Wetzier
microscope LEICA MPS 60 (Leitz Wetzlar).
Preparation of human amniotic membrane and cultivation of
autologous  epidermal  stem  cells  on  human  amniotic
membrane:  Human  amniotic  membranes  (HAMs)  were
obtained at the time of Cesarean section with proper informed
consent in accordance with the tenets of the Declaration of
Helsinki  for  research  involving  human  subjects  and  upon
approval by the Institutional Review Board of the Northwest
A&F University (Shaanxi, Yangling, China). Under sterile
conditions,  the  membranes  were  washed  with  sterile
phosphate-buffered  saline  (PBS)  containing  antibiotics
(200 IU/ml penicillin and 200 IU/ml streptomycin) then were
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1065incubated with 2.5% dispase at 4 °C for 12–20 h to loosen
cellular  adhesion  followed  by  gentle  scraping  with  a  cell
scraper and washing three times with PBS. The denuded HAM
was frozen and stored at −80 °C in pure glycerol. Immediately
before use, the HAM was thawed, washed three times with
PBS containing antibiotics, cut into approximately 4 cm x 4
cm pieces, and flattened with the stromal side on the surface
of a nitrocellulose paper (NCP) framework.
We used passage three to four putative EpiASC as seed
cells. The EpiASC (1 × 105 cells/ml) were seeded on the
denuded HAM spread upon the NCP frame in a culture dish.
The  culture  was  submerged  in  a  serum-free  medium  as
described above for one week and then exposed to air by
lowering  the  medium  level  over  a  two  week  period.  The
medium contained 80% F12, 20% GSFCM, 1%–2% BSA, 20
ng/ml  EGF,  20  ng/ml  IGF-1,  5  μg/ml  insulin,  0.5  μg/ml
hydrocortisone, 50 μg/ml Vitamin C (Sigma), and penicillin
and streptomycin (50 μg/ml each). Cultures were incubated at
37 °C in a 5% CO2/95% air incubator for up to 21 days, and
the medium was changed every day.
Creation of total limbal stem cell deficiency model: The model
of total LSCD was created in the left eye of 30 goats using a
method previously described [28] with slight modifications.
Briefly, after anesthesia, an ocular surface injury was created
in one eye of each of the 26 healthy Guanzhong dairy goats
by excising all the conjunctival tissue with 5–7 mm of the
limbus and performing a superficial keratectomy of the central
corneal surface including limbal epithelial cells, and then the
limbus was burned by mechanical erasure with 1 N NaOH.
The goats received chloramphenicol and dexamethasone eye
drops twice a day during the first week and the necessary care
for 28 days after surgery. LSCD was verified using clinical
signs  such  as  corneal  haze,  vascularization,  epithelial
irregularity, and the presence of conjunctival goblet cells on
the corneal surface.
Transplantation of autologous cultivated epidermal stem cells
on human amniotic membrane sheets: Four weeks after the
ocular surface injury, the conjunctivalized ocular surfaces of
10  goats  were  surgically  reconstructed  by  receiving
transplants  of  EpiASC-HAM  sheets  (EHS),  eight  animals
received HAM only transplantation (first control group), and
the remaining eight underwent removal of the fibrovascular
pannus without any transplantation (second control group)
[28]. After surgery, the eye was covered with sterile gauze.
From the first postoperative day, the goats were treated with
topical preservative-free 1% methyl prednisolone acetate and
0.3%  ofloxacin  four  times  a  day  and  with  intramuscular
penicillin sulfate and streptomycin sulfate every day for a
week.
Histology and immunohistochemistry: To identify whether
epidermal  stem  cells  expressed  stem  cell  markers  and  to
compare the protein expression profile of normal goat cornea
with  damaged  and  reconstructed  corneal  epithelium,  the
resultant  cells  and  corneas  were  collected,  fixed  in  4%
paraformaldehyde,  and  embedded  in  tissue  Tek  OCT
compound (Electron Microscopy Sciences, Washington, PA)
for sectioning. For hematoxylin and eosin (H&E), PAS, and
AB-PAS staining, slides were re-fixed, washed, and stained
by their respective methods. For immunofluorescent staining,
slides were re-fixed and rinsed three times (15 min each time)
in PBS that contained 0.5% Triton-X 100 and then incubated
with 2% BSA in PBS for 60 min at 37 °C. Primary antibodies
(for sources and working dilutions, see Table 1) were applied
to  tissues  for  2  h  at  37  °C.  After  washing,  fluorescein-
conjugated secondary antibodies were applied for 30 min at
37 °C. Immunofluorescence microscopy was performed with
a Nikon microscope (Nikon, Tokyo, Japan).
Immunocytochemistry staining was done by the PV-6002
Histostain™–Plus  method,  using  kits  from  Beijing
Zhongshan  Biological  and  Technological  Co.  (Beijing,
China). Sections were blocked with normal goat serum for 15
min  at  room  temperature  and  incubated  with  primary
antibodies (Table 1) overnight at 4 °C. Cells were rinsed with
0.1 M PBS without calcium and magesium and incubated with
the secondary goat anti-mouse IgG for 15 min at 37 °C. The
samples  were  washed  and  then  incubated  with  the
streptavidin/peroxidase work medium (S-A/HRP) for 15 min
at 37 °C. Cells were rinsed in 0.1 M PBS without calcium and
magesium, and the samples were finally incubated with the 3,
3′-diaminobenzidine (DAB) peroxidase substrate to give a
brown  stain  and  counterstained  with  hematoxylin  or  with
chromogen solution, BCIP/NBT, to give a blue stain. After
washing with PBS, the mounted sections were examined and
TABLE 1. PRIMARY ANTIBODIES AND SOURCES
Antibodies Category Dilution Source
CK1/10 Mouse monoclonal 50X Abcam®.
PAX-6 Mouse monoclonal 1000X Chemicon®
CK3 Mouse monoclonal 50X USBiological
CK12 Mouse monoclonal 100X Santa Cruz Biotechnology, Inc.
P63 Mouse monoclonal 200X Santa Cruz Biotechnology, Inc.
The primary antibodies used in this study and their sources.
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1066photographed  with  an  epifluorescent  microscope,  (Nikon,
Tokyo, Japan).
RESULTS
The characteristics and origin of epidermal adult stem cells:
We first cultured skin explants in a serum-based medium.
After five to six days in culture, we found epithelial-like cells
growing in a mosaic pattern surrounding the explant. Next,
small, blast-like cells with a high nuclear/cytoplasmic ratio
appeared on the surface of the epithelial-like cells. After 12–
15  days,  these  cells  formed  clones  with  diameters  of
approximately  50–100  μm  (Figure  1A).
Immunohistochemistry showed that these primary EpiASCs
either in clusters or single were Oct4 positive (Figure 1B,C).
These clones were picked under the dissecting microscope,
trypsinized  into  single-cell  suspensions,  and  cultured  in  a
serum-free medium on gelatin-coated dishes. Subsequently,
the  adherent  cells  formed  holoclones  (Figure  1D).  These
clones  were  expanded  in  vitro.  Immunohistochemistry
showed that the holoclone cells strongly expressed CK19,
Figure 1. The characteristics of epidermal adult stem cells. A: Primary EpiASC clones derived from goat ear skin formed cell clusters, 100X.
B: Clusters of primary EpiASC positively express Oct4 (9E3), 200X. C: Single primary EpiASC express Oct4 (9E3), 200X. D: Subcultured
EpiASC formed holoclones in vitro, 100X. E: Subcultured EpiASC express CK19 (A53-B/A2), 200X. F: Subcultured EpiASC express P63
(4A4), 200X. G: Subcultured EpiASC express β1-integrin (W1B10), 200X. H: Subcultured EpiASC express CD34, 100X. I: Part of the
subcultured EpiASC expresses Oct4, 200X. The scale bar represents 100 μm.
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1067P63, β1-integrin, and CD34, a group of previously reported
EpiASC  markers  (Figure  1E-H).  Surprisingly,  we  found
~50%of subcultured EpiASC still strongly expressing Oct4
(Figure 1). To confirm the origin of isolated EpiASC, we
separated  the  epidermis  from  the  dermis  by  dispase  II
treatment and cultured both of them in the same medium. After
three to four days, we found that cells that were derived from
the epidermis expand in a mosaic pattern (Figure 2A), which
is  different  from  the  fibroblast  cells  derived  from  dermis
(Figure 2B). After 8–10 days, cell clones were formed in the
surface of epithelial cells, which exhibited the same properties
as stem-like cell clones from total skin explant culture (Figure
2C). In contrast, the fibroblast cells became confluent, and no
stem-like cell clones were observed (Figure 2D). These results
showed that EpiASC are derived from the epidermis of the
skin.
Human amniotic membrane serves as a niche for epidermal
adult stem cells: Preserved HAM transplantation alone was
previously shown to be sufficient to reconstruct the corneal
surface  in  cases  of  partial  LSCD  [31,32],  suggesting  that
HAM may help expand the residual limbal epithelial stem
cells. Clinical and experimental studies have also shown that
ex vivo-expanded limbal epithelial cells on HAM are capable
of restoring the corneal surface in LSCD [32]. Meller et al.
[33]  provided  evidence  that  HAM  cultures  preferentially
preserve and expand limbal epithelial stem cells that maintain
their in vivo properties of slow cycling, label retention, and
undifferentiation. We proposed that HAM might be an ideal
matrix for ex vivo preservation and expansion of EpiASC. To
investigate this, we seeded EpiASC that were isolated from a
single cell (Figure 3A) on denuded HAM (Figure 3B). The
culture was submerged in a serum-free medium for one week
and then exposed to air by lowering the medium level over
two weeks. We found that EpiASC adhered to HAM within
20–30 min, forming EHS. EpiASC remained quiescent during
the first two days and then proliferated quickly during a further
three days culture. We also observed that EpiASC formed
clones in a similar way when co-cultured with 3T3 cells [data
not shown]. To promote EpiASC proliferation, we exposed
the surface of EHS to the air a week after culture and added
50 μg/ml Vitamin C to the medium. We found that EpiASC
proliferation was arrested and differentiation had begun. The
surface  of  EHS  was  covered  with  flattened  cells,  which
expressed CK1/10 (Figure 3C). When the EHS was digested
with 0.25% trypsin for 20–25 min, we found that a single cell
layer was firmly attached to the HAM. Staining with anti-P63
antibody revealed that P63-positive cells were surrounded by
groups of P63-negative cells (Figure 3D). This suggested that
in the serum-free culture conditions, EpiASC reconstructed
their  niche  on  the  surface  of  HAM.  Immunostaining  also
showed that the P63 expression pattern of the EHS (Figure
3E)  was  similar  to  the  pattern  observed  within  the  basal
membrane layer of corneal epithelium (Figure 3F), further
evidence that HAM can serve as a niche for EpiASC and can
support EpiASC proliferation in vitro.
Figure 2. Morphological properties of
cells  derived  from  the  epidermis  are
distinct  from  cells  derived  from  the
dermis. A: After about 3 to 4 days in
culture, cells derived from the epidermis
expand in a mosaic way, self renewing
cells appeared on the surface of the cell
layer (red arrow). B: Shows fibroblast
cells derived from the dermis. C: After
about 8 to 10 days, stem-like cell clones
formed on the surface of the epithelial
cell layer (red arrow). D: After 8~10
days fibroblasts derived from the dermis
became  confluent  and  stem-like  cell
clones were not observed.
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1068Clinical results of transplantation of EpiASC-HAM sheet to
the  corneal  surface:  We  have  previously  reported  the
phenotypic outcome of transplantation of EHS to the corneal
surface of total LSCD with a follow-up period of 24 months
[28]. During this study, with an average follow-up period of
30 months, approximately 30% (3/10) of the eyes of treated
animals regained four quadrants of clear cornea. This was
assessed as a success according to the criterion of Ti et al.
[29]. However, part of the limbus of these three eyes was
unclear, which is distinct from normal eyes (Figure 4A-D).
Half (5/10) of the eyes of the treated animals regained three
quadrants of clear cornea, which was deemed a partial success
[29], but the further limbus of these eyes was opaque (Figure
4E-G).  The  remaining  20%  (2/10)  failed  to  regain  two
quadrants of clear cornea (data not shown). The corneas of the
control eyes were covered with pannus (Figure 4H,I), which
manifested as vascularization and chronic inflammation of the
cornea, ingrowth of fibrous tissue, and corneal opacification.
Epidermal adult stem cells can be converted into corneal
epithelium by corneal stroma: We have previously reported
that  autologous  EpiASC  transplantation  reconstructs  the
ocular surface of total LSCD to functionality [28], which only
involves the morphological and histological features of the
reconstructed ocular surface. However, the fate of grafted
EpiASC after transplantation was not studied. In the present
study, we compared the features of normal corneal epithelium
(NCE),  reconstructed  cornea  epithelium  (RCE),  and  the
pannus  (P)  of  control  groups  by  H&E,  PAS,  and
immunocytochemistry  staining.  The  results  showed  that
reconstructed  cornea  shares  certain  features  with  normal
cornea  such  as  the  corneal  surface  was  smooth  and  the
epithelium was integral without goblet cells (Figure 5A,B). In
contrast, the corneal surface in the control group was covered
with fibers, blood vessels, and goblet cells (Figure 5C,D).
Interestingly, AB-PAS staining showed that both normal and
reconstructed  corneal  epithelium  were  red  (Figure  5E,F),
which is characteristic of neutral mucus. In contrast, the goblet
cells  in  the  control  group  were  purple  (Figure  5G),
characteristic of mixed mucus. These findings suggest that the
corneal epithelium of reconstructed cornea has a function of
secretion similar to normal corneal epithelium and distinct
from invading goblet cells.
To  confirm  whether  EpiASC  may  serve  as  LSCs  to
functionally  reconstruct  the  damaged  cornea  of  LSCD,  a
series of markers of corneal epithelium were compared among
NCE, RCE, and P. The results showed that the RCE and NCE
exhibit similar expression profiles of CK3, CK12, and PAX-6
(Figure 5H-M). The pannus expressed PAX-6 (Figure 5N) but
Figure 3. Human amniotic membrane serving as a niche for epidermal adult stem cells and the formation of EpiASC-HAM sheet. A: Passage
3 epidermal stem cell was used as seed cell to reconstruct artificial corneal epithelium, 100X. B: EpiASC cultured on HAM for 30 min, 100X.
C: EpiASC cultured on HAM for 20 days and differentiated into keratinocytes expressing CK1/10 (ab20121), 100X. D: P63-positive EpiASC
surrounded by P63-negative cells, showing EpiASC reconstructing a niche on HAM, 100X. E: P63-positive pattern of ESH, 200X. F: P63
(4A4) expression in a wavy pattern along the basal membrane of normal corneal limbus, 200X. The scale bar represents 100 μm.
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1069not CK3 (Figure 5O). These data provide good evidence that
EpiASC regenerated the function of damaged corneal surface
caused by total LSCD.
Although we could not provide direct evidence that the
reconstructed corneal epithelium were derived from grafted
EpiASC (because of the lack of a valid marker to trace the fate
of  EpiASC  during  host  wound  repair),  there  is  indirect
evidence suggesting that the reconstructed corneal epithelium
derives from grafted EpiASC. To show this, the expression
profiles both of CK1/10 and PAX-6 were compared in normal
skin (NS) and RCE six months after the operation and 12
months after the operation. We found that the expression of
CK1/10 in NS is much greater than in RCE six months after
operation  (Figure  6A-B);  however,  PAX-6  was  strongly
expressed in the nucleus of epithelial cells in the RCE (Figure
6C). Interestingly, CK1/10 was also expressed in the cell
cytoplasm of limbal and central corneal epithelial basal layer,
which is different from the normal location of CK1/10 in NS
(Figure  6D).  NS  is  typically  expressed  in  the  superficial
epithelial cells. Furthermore, CK1/10 was not expressed by
the RCE 12 months after the operation (Figure 6E) while
PAX-6 was strongly expressed in the nucleus of epithelial
cells of the RCE (Figure 6F). This suggests that the expression
of CK1/10 was down-regulated by the corneal stroma of the
host  animal  during  the  process  of  corneal  epithelium
regeneration and that PAX-6 expression was upregulated.
DISCUSSION
For treatment of severe ocular surface diseases such as SJS
and OCP, it is crucial to find a strategy that avoids the risks
of  allogeneic  immunorejection  and  immunosuppression.
Recent progress in this field is encouraging and suggests that
autologous  oral  mucosal  epithelial  cells  [34-36],
Figure 4. Clinical results of transplantation of EpiASC-HAM sheet to the damaged corneal surface. A: Untreated goat eye is showing a normal
cornea. B–D: Three of the experimental eyes regained four quadrants of clear cornea and were deemed successful reconstructions. E-G: Three
of the experimental eyes regained three quadrants of clear cornea and were deemed partial successes for reconstruction. H: The reconstructed
ocular surface of total LSCD without transplantation was covered with vascularized pannus. I: The reconstructed ocular surface of total LSCD
with HAM only transplantation was also covered with vascularized pannus.
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1070Figure 5. Epidermal adult stem cells can be converted into corneal epithelium by corneal stroma. A: PAS staining of the normal cornea
epithelium showed no goblet cells, 200X. B: PAS staining of the reconstructed cornea epithelium also show no goblet cells, 200X. C-D: PAS
staining shows the invaded goblet cells in the corneal surface of control group, 200X. The black arrow in C is pointing to the invaded goblet
cells, the red arrow in D is pointing to the blood vessels. E: Normal cornea is shown, and the AB-PAS staining is red, characteristic of neutral
mucus, 200X. F: The reconstructed cornea is shown, and the AB-PAS staining is also red, characteristic of neutral mucus, 200X. G: AB-PAS
staining show goblet cells as purple, which is characteristic of mixed mucus, 200X. The red arrow in G is pointing to the goblet cells in the
corneal epithelium of control group which were stained purple by the AB-PAS staining method. The results of immunohistochemistry showed
that normal cornea epithelium (H) expressed CK3 (I.BB.787), 400X, as well as reconstructed cornea epithelium (I) expressed CK3, 400X.
Both normal cornea epithelium (J) and reconstructed cornea epithelium (K) expressed CK12 (SC-17099) which is a specific marker for
differentiated corneal epithelium, 400X. Furthermore, both of normal cornea epithelium (L) and reconstructed cornea epithelium (M)
expressed PAX-6 (AB5409), 400X. Although the reconstructed epithelium of control group (N) expressed PAX-6 (AB5409), it did not express
CK3 (O), showing that this kind of epithelium derived from the control group did not share the character with normal corneal epithelium,
200X. The scale bar represents 100 μm.
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1071mesenchymal stem cells [37], and conjunctival epithelial cells
[38] may serve as alternative seed cells for treating these
severe ocular surface diseases. The present study shows that
tissue-engineered cell sheets composed of adult epidermal
stem cells can successfully reconstruct the damaged cornea of
total LSCD in goats. Ten LSCD goats (10 eyes) were treated
with  this  approach,  leading  to  the  restoration  of  corneal
transparency and improvement of postoperative visual acuity
to varying degrees in 80% (8/10) of the experimental eyes. In
comparison, the corneal epithelium of two control groups
either with HAM transplantation only (n=8) or without any
transplantation  (n=8)  showed  irregular  surfaces,  diffuse
vascularization,  and  pannus  on  the  entire  cornea.  The
reconstructed corneal epithelium expressed CK3, CK12, and
PAX-6  and  had  the  function  of  secreting  glycocalyx-like
material (AB-PAS positive). During the follow-up period, all
corneal  surfaces  remained  transparent  and  there  were  no
serious complications.
The  ocular  surface  of  either  human  or  animal  origin
exposed outside of the body is suitable to observe and evaluate
the outcome of transplant experiments. This fact along with
the well defined locations of different cell types within the
cornea provides a useful model for studying the plasticity of
adult stem cells. EpiASC as well as other adult stem cells
readily lose their stemness during their propagation in vitro.
To  overcome  this  problem,  we  developed  a  serum-free
medium  containing  fibroblast  cell-conditioned  medium  to
culture EpiASC, and we selected HAM as a substrate to carry
EpiASC for fabricating ESH. Many studies have shown that
HAM can serve as a niche for limbal stem cells to maintain
their stemness in vitro [32,39]. Our own results showed that
P63-positive cells were strictly located to the basal layer of
the ESH on day 21 of culture and suggested that HAM is a
suitable carrier for EpiASC to maintain stemness.
During  the  process  of  repairing  the  damaged  ocular
surface of LSCD in goat, the CK1/10 marker was down-
regulated by corneal stroma. This is indirect evidence that
EpiASC can survive in the host tissue and can be induced into
corneal epithelium in vivo, which expresses CK3, CK12, and
PAX-6.  These  results  also  suggest  that  the  probable
mechanism of EpiASC reconstruction of the damaged ocular
surface  of  total  LSCD  involves  the  down-regulation  of
CK1/10 and upregulation of PAX-6 by the factors derived
from corneal stroma. PAX-6 is a master gene that controls eye
formation during embryonic development [40,41]. Pearton et
al. [14] suggested that transdifferentiation of epithelium into
Figure 6. The expression profile of CK1/10 and PAX-6 in normal skin and reconstructed cornea epithelium  6  months after the operation and
12 months after the operation. A: CK1/10 (ab20121) was highly expressed in the cell cytoplasm of superficial epithelial cells of NS, 200X.
B: CK1/10 (ab20121) was weakly expressed in the cell of reconstructed limbal epithelial basal layer six months after transplantation, 200X.
C: CK1/10 (ab20121) was weakly expressed in the cell cytoplasm of RCE superficial epithelial cells six months after transplantation, 200X.
D: PAX-6 (AB5409) was expressed in the nucleus of epithelial cells of RCE six months after the operation, 200X. E: CK1/10 (ab20121) was
not expressed by RCE 12 months after the transplantation, 200X. F: PAX-6 (AB5409) was expressed in the nucleus of epithelial cells of RCE
12 months after the operation, 200X. The scale bar represents 100 μm.
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1072epidermis occurs through a multi-step process that is triggered
by dermal developmental signals, which involves the down-
regulation of PAX-6, loss of expression of corneal-specific
keratins, and induction of basal keratinocyte markers [14].
This evidence supports the proposal that PAX-6 plays a crucial
role in eye development [40,41]. More work is needed to
monitor how and when the silenced PAX-6 in EpiASC is
reactivated and the CK1/10 gene is down-regulated by the
corneal  stroma.  In  turn,  this  work  will  shed  light  on  the
reconstruction mechanism of the damaged ocular surface of
total LSCD by EpiASC transplantation.
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